Cargando…

MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer

The present study assessed the role of metastasis-associated protein 1 (MTA1) in epithelial to mesenchymal transition (EMT) and metastasis in non-small-cell lung cancer (NSCLC) cells using a normal lung epithelium cell line, three NSCLC cell lines, a mouse NSCLC model, and 56 clinical NSCLC samples....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ke, Fan, Yangwei, Dong, Xuyuan, Dong, Danfeng, Guo, Yuyan, Wei, Xin, Ning, Jing, Geng, Qianqian, Wang, Chuying, Hu, Yuan, Li, Mengya, Niu, Wenxia, Li, Enxiao, Wu, Yinying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503575/ https://www.ncbi.nlm.nih.gov/pubmed/28418915 http://dx.doi.org/10.18632/oncotarget.16404

Ejemplares similares

Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors
por: Fan, Yangwei, et al.
Publicado: (2016)

α‐Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades
por: Shi, Yu, et al.
Publicado: (2019)

Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review
por: Wu, Yinying, et al.
Publicado: (2020)

Molecular classification of esophagogastric junction carcinoma correlated with prognosis
por: Zou, Long, et al.
Publicado: (2017)

Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways
por: Hu, Yuan, et al.
Publicado: (2021)

Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells
por: Shi, Yu, et al.
Publicado: (2021)

PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma
por: Ma, Ke, et al.
Publicado: (2017)

Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells
por: Fan, Yangwei, et al.
Publicado: (2020)

A Sensitive and Selective Method for Determination of Aesculin in Cortex Fraxini by Liquid Chromatography Quadrupole Time-of-Flight Tandem Mass Spectrometry and Application in Pharmacokinetic Study
por: Li, Yi, et al.
Publicado: (2013)

Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer
por: Wu, Yinying, et al.
Publicado: (2017)

MTA1, a Target of Resveratrol, Promotes Epithelial-Mesenchymal Transition of Endometriosis via ZEB2
por: Kong, Xiangyi, et al.
Publicado: (2020)

Clinical characteristics and treatment of 69 patients with extranodal natural killer T-cell lymphoma
por: Guo, Yuyan, et al.
Publicado: (2016)

High glucose promotes hepatic fibrosis via miR-32/MTA3-mediated epithelial-to-mesenchymal transition
por: Li, Qiang, et al.
Publicado: (2019)

High glucose promotes hepatic fibrosis via miR-32/MTA3-mediated epithelial-to-mesenchymal transition
por: Li, Qiang, et al.
Publicado: (2022)

Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis
por: Dong, Yinying, et al.
Publicado: (2019)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transition
por: Liu, Jie, et al.
Publicado: (2017)

HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma
por: YANG, HAIXIA, et al.
Publicado: (2015)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2019)

Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non–Small Cell Lung Cancer Cells
por: Dong, Xuyuan, et al.
Publicado: (2016)

TP53I11 suppresses epithelial-mesenchymal transition and metastasis of breast cancer cells
por: Xiao, Tongqian, et al.
Publicado: (2019)

Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition
por: Dong, Zhizhen, et al.
Publicado: (2018)

Tspan5 promotes epithelial–mesenchymal transition and tumour metastasis of hepatocellular carcinoma by activating Notch signalling
por: Xie, Qian, et al.
Publicado: (2021)

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
por: Xu, Jiahui, et al.
Publicado: (2017)

Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma Cells
por: Wang, Zheng, et al.
Publicado: (2013)

Downregulation of iNOS/NO Promotes Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Du, Qiang, et al.
Publicado: (2023)

Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer
por: Xu, Jiahui, et al.
Publicado: (2023)

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
por: Campbell, Kyra
Publicado: (2018)

Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma
por: Goulioumis, Anastasios, et al.
Publicado: (2022)

Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition
por: Jing, Yingying, et al.
Publicado: (2012)

Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial-to-mesenchymal transition
por: Li, Qiu-Hua, et al.
Publicado: (2020)

Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis
por: Park, Pil-Gu, et al.
Publicado: (2017)

SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer
por: Qi, Honggang, et al.
Publicado: (2017)

Exposing the Underlying Relationship of Cancer Metastasis to Metabolism and Epithelial-Mesenchymal Transitions
por: Kang, Xin, et al.
Publicado: (2019)

Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma
por: Hao, Chong, et al.
Publicado: (2014)

Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer
por: Chen, Dong-liang, et al.
Publicado: (2017)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma
por: Liu, Mengwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_554u1di7ldc40em8n62rq9vhr3